Madrigal Pharmaceuticals
MDGL
#2088
Rank
HK$69.02 B
Marketcap
HK$2,972
Share price
-4.45%
Change (1 day)
-30.31%
Change (1 year)

EPS for Madrigal Pharmaceuticals (MDGL)

EPS in 2026 (TTM): -HK$46.17

According to Madrigal Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -HK$46.33. In 2025 the company made an earnings per share (EPS) of -HK$83.79 an increase over its 2024 EPS that were of -HK$173.31.

EPS history for Madrigal Pharmaceuticals from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$46.17-44.9%
2025-HK$83.79-51.65%
2024-HK$173.31
2022-HK$135.0617.93%
2021-HK$114.5211.61%
2020-HK$102.61140.18%
2019-HK$42.72146.61%
2018-HK$17.32-12.99%
2017-HK$19.91-91.03%
2016-HK$221.91

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-HK$1.49-96.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-HK$7.45-83.93%๐Ÿ‡บ๐Ÿ‡ธ USA